Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Versatile Role of GDF5 in Chondrogenic Progenitor Cell-mediated Cartilage Regeneration via a Hyaluronic Acid-fibrin IPN Hydrogel Platform. | Pharm Res | 2026 | 41981216 | PubTator, text mining | PubMed |
| ZDHHC14 Attenuates Osteoarthritis Progression through Metabolic Pathways: Multi-omics Fusion and Functional Validation. | Exp Gerontol | 2026 | 41962640 | PubTator, text mining | PubMed |
| Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease. | Aging Cell | 2026 | 41933123 | PubTator, text mining | PubMed |
| Research progress of mesenchymal stem cells/stromal cells and their derivatives against cell senescence in the treatment of osteoarthritis. | Ann Med | 2026 | 41919394 | PubTator, text mining | PubMed |
| An Overview of ADAMTS Proteases. | Methods Mol Biol | 2026 | 41917349 | PubTator, text mining | PubMed |
| Natural photosynthetic system for restoring homeostasis of animal organelle interaction network. | Nat Commun | 2026 | 41916969 | PubTator, text mining | PubMed |
| Computational Insights into Flavonoids for ADAMTS-5 Exosite Inhibition in Knee Osteoarthritis: Docking, MD Simulations, and Machine Learning-Guided Structure Prediction. | Molecules | 2026 | 41900115 | PubTator, text mining | PubMed |
| Epigenetics of Genes Displaying High and Preferential Expression in Myoblasts. | Epigenomes | 2026 | 41892369 | PubTator, text mining | PubMed |
| TRPC6-Mediated Ca2+ Influx Activates MAPK and NFκB Signaling and Elicits Pro-Inflammatory and Catabolic Responses in Human Intervertebral Disc Cells. | Cells | 2026 | 41892324 | PubTator, text mining | PubMed |
| Identification of ADAMTS5 as APP-Cleaving Enzyme at the APP669 Site. | FASEB J | 2026 | 41891882 | PubTator, text mining | PubMed |
| Dimeric PKM2 in chondrocytes impairs mitochondrial homeostasis in osteoarthritis. | Cell Death Dis | 2026 | 41881976 | PubTator, text mining | PubMed |
| Micro-nano integrated platforms for osteoarthritis therapy: From spatial manipulation to cellular reprogramming. | Mater Today Bio | 2026 | 41800455 | PubTator, text mining | PubMed |
| Collagen II hydrogel-mediated sustained delivery of lacosamide attenuates cartilage degeneration and pain in osteoarthritis. | Bioact Mater | 2026 | 41799961 | PubTator, text mining | PubMed |
| Artemisia argyi-enhanced Mesenchymal Stem Cell Exosomes Alleviates Inflammation in C28/I2 Chondrocytes by inhibiting NF-κB. | Int J Med Sci | 2026 | 41799761 | PubTator, text mining | PubMed |
| Genetics and pathophysiology of diffuse idiopathic skeletal hyperostosis. | Front Endocrinol (Lausanne) | 2026 | 41782748 | PubTator, text mining | PubMed |
| Correction to "Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF-κB Pathway". | Oxid Med Cell Longev | 2026 | 41778201 | PubTator, text mining | PubMed |
| Self-Assembled Hydrogels: A Novel Drug Delivery System for Osteoarthritis. | Curr Issues Mol Biol | 2026 | 41751473 | PubTator, text mining | PubMed |
| The protective up-regulation of metallothionein-2A in intervertebral disc degeneration inhibits nucleus pulposus cell ferroptosis through activation of the PI3K/AKT/mTOR pathway. | Cell Death Discov | 2026 | 41741409 | PubTator, text mining | PubMed |
| Adamts4 coordinates the transcriptomic profile of primary rat costal chondrocytes. | Stem Cells Transl Med | 2026 | 41736693 | PubTator, text mining | PubMed |
| Melatonin attenuates oxidative stress-induced ferroptosis of nucleus pulposus cells and intervertebral disc degeneration via PI3K/AKT-mTOR pathway. | Int J Surg | 2026 | 41729690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=3